New Start in Middle East

Abu Dhabi, Nov. 29, 2023 – Joy Capital and Ehome Health, today jointly announces their plan to incorporate joint-venture companies (“JVs”) in ADGM and Abu Dhabi, to develop localized, desk-top blood and immunity testing devices for South Asia, the Middle East and Africa markets.

Ehome is a world-leading desk-top, stand-alone blood and immunity testing device maker. It’s devices can produce accurate testing results in 5-15 minutes on the spot, reducing testing turn around time dramatically. Ehome’s big data based digital technology also uses only a fraction of energy as the traditional laboratory equipment.
Joy Capital is committed to provide financial funding to build and grow the Abu Dhabi based JVs, to manufacture made-in-UAE products for the regions.  

“We carry a strong sense of social responsibility to bring Ehome technology to the public healthcare sector in the regions because it enables millions of people living outside of the modern healthcare coverage real-time, on-the-spot certified blood and immunity testing services,” said Mr. Leenong Li, the designated SEO (senior executive office) of Joy Global, “Ehome’s low-cost, desk-top solutions empower healthcare workers in hundreds of thousands rural, community clinics to same diagnostic capabilities as their peers in high-end hospitals. As one of the earliest investors in Ehome, we are proud of what the Ehome team has developed and how well they are serving the China market today.” “The Ehome JVs here have our absolute commitment of financial supports and I can’t wait to see its services flourish throughout the regions”, Li continued.

 “It has taken Ehome and myself more than a decade of persistent research and development, to turn a simple dream into the reality,” said founder/CEO Shuang Hu, “I cannot be happier to see Ehome technology benefiting millions of people living in the regions. Joy Global is our best partner here not only because they have been our strongest financial supporter from day one, but also being our mentor and friend here in Abu Dhabi. I truly enjoy working with Leenong and listening to his advice on our international strategy.”

Ehome Health, the leading POCT manufacturer in China since its foundation in 2014, dedicating to the innovation of cell morphology technology, developing, manufacturing and marketing on POCT products,Ehome health occupies over 8700m manufacturing base with over 500 employees, the self-run biological,optical and hardware laboratories together with capacity of 5000pcs equipment per month makes Ehome health No. 1 in the primary medical care market in China.